SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-08-027792
Filing Date
2008-05-12
Accepted
2008-05-12 16:50:28
Documents
6

Document Format Files

Seq Description Document Type Size
1 v113776_sc13da.htm SC 13D/A 80221
2 v113776_ex99-4.htm EX-99.4 971
3 GRAPHIC v113776_ex99-4x1x1.jpg GRAPHIC 86456
4 GRAPHIC v113776_ex99-4x2x1.jpg GRAPHIC 59463
5 GRAPHIC v113776_ex99-4x3x1.jpg GRAPHIC 38874
6 GRAPHIC v113776_ex99-4x4x1.jpg GRAPHIC 20373
  Complete submission text file 0001144204-08-027792.txt   366441
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Subject) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-37761 | Film No.: 08824052
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address SALISBURY HOUSE, STATION ROAD, CAMBRIDGE X0 CB1 2L
Business Address SALISBURY HOUSE, STATION ROAD, CAMBRIDGE X0 CB1 2L 44 207 932 2100
Lorantis Holdings LTD (Filed by) CIK: 0001430324 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0
Type: SC 13D/A